Insight

Jan 21, 2025, 17:00

5 papers about lung cancer by Stephen Liu

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

1. A Retrospective Evaluation of PD-L1 expression and heterogeneity in early-stage non-small cell lung Cancer (REPLICA)

Authors: Eleni Josephides et al.

lung cancer

2. Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group

Authors: L. Decoster, D.R. Camidge, J.A. Fletcher, A. Addeo, A. Greystoke, K. Kantilal, L. Bigay Gameh, R. Kanesvaran, F. Gomes

lung cancer

3. A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab, as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13 18 BEAT-meso trial

Authors: E. Felip et al.

lung cancer

4. Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial

Authors: Wan-Qin Chong et al.

lung cancer

5. A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET)

Authors: Hiroaki Akamatsu et al.

lung cancer

More posts featuring Stephen Liu on OncoDaily.

A. Addeo A. Greystoke A. Pope A. Scherz Akshay Patel Ana Montes Andrea Bille Anil Gopinathan Annie-Rose Henry B. Massuti B. Ruepp Bee-Choo Tai cancer D.R. Camidge Daisuke Nonaka Daniel Hughes Daniel Smith Danielle Crawley Debra Josephs Donovan Kum-Chuen Eu E. Felip E. Nadal Eleni Josephides Eleni Karapanagiotou F. de Marinis F. Gomes G. Dimopoulou George Santis Grace Shi-Qing Goh H. Roschitzki-Voser Hannah Rush Hao Li Haruko Daga Hiroaki Akamatsu Hiroshige Yoshioka Hui-Lin Teo J.A. Fletcher James Spicer Jens Samol Jia-Li Low Joshua K Tay K. Kantilal K. Nackaerts K. Ribi Kana Watanabe Kenneth Sooi Kiichiro Ninomiya Koichi Azuma L. Bigay Gameh L. Cove Smith L. Decoster L. Greillier L. Vila Martinez Li-Ren Kong Lingzhi Wang Lung cancer M. Früh Maria Monroy-Iglesias Mieke Van Hemelrijck Ming-Yann Lim Mitsuo Osuga Nicholas Syn Niranjan Shirgaonkar Nobuyuki Yamamoto NSCLC OncoDaily Oncology Phillipe Taniere Prof Boon-Cher Goh Prof Han-Chong Toh Prof Kwok-Seng Loh R. Bernabé R. Kanesvaran R. Shah R. Stahel Ramanuj Dasgupta Raymond King-Yin Tsang Regina Tong-Xin Wong Roberta Dunn Ryo Toyozawa S. Cedres S. Peters S. Popat S. Savic S. Schär Sarah Hunter Satoshi Morita Seiya Esumi Seng-Wee Cheo Shinya Sakata Shumei Chia T. Talbot Takashi Kurosaki Takehiro Uemura Takehito Shukuya Terufumi Kato Thi Bich Uyen Le Tomohiro Sakamoto Toshiaki Takahashi Toshiyuki Kozuki U. Dafni Wan-Qin Chong Yasuhiro Koh Yasuto Yoneshima Yaw-Chyn Lim Yuki Sato Yuko Tsuchiya-Kawano

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025